A decrease in Jak1 degradation was found in RPL10-R98S mutant cells and led to activation of the JAK-STAT signaling pathway, an established oncogenic driver in T-ALL.198 These findings thus highlight the critical role of metabolic reprogramming in RP mutation-driven oncogenesis. Here, RPL10 is linked to acute lymphoblastic leukemia.